The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index; 1 of the 56 sources its claims cite were checked for support.
A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)
Open accessAbstract
AIMS/HYPOTHESIS: The aim of this study was to develop a simulation model for type 2 diabetes that can be used to estimate the likely occurrence of major diabetes-related complications over a lifetime, in order to calculate health economic outcomes such as quality-adjusted life expectancy. METHODS: Equations for forecasting the occurrence of seven diabetes-related complications and death were estimated using data on 3642 patients from the United Kingdom Prospective Diabetes Study (UKPDS). After examining the internal validity, the UKPDS Outcomes Model was used to simulate the mean difference in expected quality-adjusted life years between the UKPDS regimens of intensive and conventional blood glucose control. RESULTS: The model's forecasts fell within the 95% confidence interval for the occurrence of observed events during the UKPDS follow-up period. When the model was used to simulate event history over patients' lifetimes, those treated with a regimen of conventional glucose control could expect 16.35 undiscounted quality-adjusted life years, and those receiving treatment with intensive glucose control could expect 16.62 quality-adjusted life years, a difference of 0.27 (95% CI: -0.48 to 1.03). CONCLUSIONS/INTERPRETATIONS: The UKPDS Outcomes Model is able to simulate event histories that closely match observed outcomes in the UKPDS and that can be extrapolated over patients' lifetimes. Its validity in estimating outcomes in other groups of patients, however, remains to be evaluated. The model allows simulation of a range of long-term outcomes, which should assist in informing future economic evaluations of interventions in type 2 diabetes.
Overview
CoChat Summary
## TL;DR
The paper develops the UKPDS Outcomes Model, a simulation model for Type 2 diabetes that estimates lifetime risk of seven complications and death from data on 3,642 UKPDS patients. It fits the observed UKPDS outcomes closely and estimates that intensive glucose control yields 0.27 more undiscounted QALYs over a lifetime than conventional control, though external validity remains untested.
## Key findings
- The model was fit using data from 3,642 UKPDS patients, with 39,460 person-years of follow-up and a median follow-up of 10.3 years.
- Internal validation showed the model’s forecasts fell within the 95% confidence interval for observed events during follow-up, and the simulated cumulative incidence for the seven diabetes-related complications and all-cause mortality was within the observed 95% CIs up to 12 years from diagnosis.
- For UKPDS patients treated under the trial protocol, the model estimated 16.35 undiscounted QALYs for conventional glucose control and 16.62 for intensive control, a difference of 0.27 QALYs (95% CI: -0.48 to 1.03).
- Example life expectancy estimates for patients diagnosed at 45–49 years were 25.54 years for men and 26.80 years for women; corresponding quality-adjusted life expectancy was 18.82 and 20.06 QALYs, respectively.
## Methods
- The paper developed a probabilistic discrete-time illness-death simulation model with annual cycles to estimate first occurrence of seven diabetes-related complications (MI, other IHD, stroke, heart failure, amputation, renal failure, and blindness in one eye) plus death.
- Event equations were estimated from 3,642 UKPDS patients using Weibull proportional hazards regression for complications, logistic regression for fatality after first events, Gompertz regression for diabetes-related and other mortality, and random-effects panel data regression for progression of HbA1c, systolic BP, total cholesterol:HDL, and smoking status.
- The model was internally validated by comparing simulated cumulative incidence with non-parametric life-table estimates, and uncertainty was handled with bootstrap plus multiple imputation methods.
## Limitations
- The paper states the model only predicts the first event in any single category of diabetes-related complications and does not directly model sequences such as sequential amputations.
- The paper states it does not explicitly incorporate some diabetes-related morbidities, notably peripheral neuropathy and ulceration, and also excludes hypoglycaemia and hyperglycaemia as modeled outcomes.
- The paper states that external validity remains to be evaluated; this is reinforced by the text’s caution that the model should be used carefully in other populations.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 2 Not valid · 40 Not checked · 70 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“those receiving treatment with intensive glucose control could expect 16.62 quality-adjusted life years”
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“a difference of 0.27 (95% CI: -0.48 to 1.03)”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“those treated with a regimen of conventional glucose control could expect 16.35 undiscounted quality-adjusted life years”
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The model's forecasts fell within the 95% confidence interval for the occurrence of observed events during the UKPDS follow-up period.”
plainn = 3,642- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The corresponding mean quality-adjusted life expectancy is estimated to be 18.82 (95% CI: 16.48-21.15) QALYs.”
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
53 more claims
Create a free account to see all 113 claims and to verify the 55 references still open.
- Probably not a substantial claim. 45
- It may state two separate claims as one. 19
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The UKPDS-OM1 was based on trial data collected in the UKPDS up until 1997.”
From UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82 (2013) · cites this paper as [1]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Individual-level STMs [36,37], however, require more computation time, which may be important if probabilistic sensitivity analyses or value-of-information analyses are performed.”
From State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3 (2012) · cites this paper as [37]
Citations
Cites
(1998) · The Lancet · doi:10.1016/s0140-6736(98)07019-6 · Cited by 20,023
Self-citationEuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Self-citationTurner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Self-citationGupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,006
Schafer, J. L. (1999) · Statistical Methods in Medical Research · doi:10.1177/096228029900800102 · Cited by 3,949 · cited 2×
“Standard methods for combining the results of multiple imputations were then employed [31], including a bias correction to adjust for the fact that a (relatively) small number of multiple imputa1758 P.”
MethodPetry, F. E. (1997) · Kluwer Academic Publishers eBooks · Cited by 2,303
Cardiovascular disease risk profiles
Anderson, K. M., Odell, P. M., Wilson, P. W. F., & Kannel, W. B. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90861-b · Cited by 2,163 · cited 1×
“Parametric methods for risk estimation have previously been applied in modelling events such as MI and stroke [34, 35, 36].”
MethodAdler, A. I. (2000) · BMJ · doi:10.1136/bmj.321.7258.412 · Cited by 2,133 · cited 1×
“Observational analyses using data from the UKPDS have examined the relationship between exposure to glycaemia [8] and levels of systolic BP [9] over time, and the development of macrovascular and microvascular complications.”
MethodSelf-citationAdler, A. I., Stevens, R. J., Manley, S. E., Bilous, R. W., Cull, C. A., Holman, R. R., & UKPDS Group (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00712.x · Cited by 1,816
Self-citation
Cited by
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Chan, J. C. N., Lim, L.-L., Wareham, N. J., Shaw, J. E., Orchard, T. J., Zhang, P., Lau, E. S. H., Eliasson, B., Kong, A. P. S., Ezzati, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32374-6 · Cited by 793
Self-citationYoung, B. A., Lin, E. H. B., Korff, M. V., Simon, G., Ciechanowski, P. S., Ludman, E. J., Everson‐Stewart, S., Kinder, L. S., Oliver, M. M., Boyko, E. J., et al. (2008) · PubMed · Cited by 686
State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3
Siebert, U., Alagoz, O., Bayoumi, A. M., Jahn, B., Owens, D. K., Cohen, D. J., & Kuntz, K. M. (2012) · Value in Health · doi:10.1016/j.jval.2012.06.014 · Cited by 588
Proceedings of the 2004 Winter Simulation Conference, 2004.
(2004) · doi:10.1109/wsc.2004 · Cited by 587
Hayes, A. J., Leal, J., Gray, A. M., Holman, R. R., & Clarke, P. M. (2013) · Diabetologia · doi:10.1007/s00125-013-2940-y · Cited by 495
Self-citation
Metadata
- Authors
- Clarke, P. M., Gray, A. M., Briggs, A., Farmer, A. J., Fenn, P., Stevens, R. J., Matthews, D. R., Stratton, I. M., Holman, R. R., & on behalf of the UK Prospective Diabetes Study (UKPDS) Group
- Affiliations
- University of Oxford (GB)
- University of Nottingham (GB)
- Churchill Hospital (GB)
- Corresponding author
- Clarke, P. M.
- ORCID
- Venue
- Diabetologia
- Published
- 2004-10
- Volume
- 47
- Issue
- 10
- Pages
- 1747-1759
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2126252058
- Semantic Scholar
- cd1dc97c76aceb7967f69f82eb58318cd4f96d6c
- Cited by
- 615
- References
- 42
- Citations by year
- 2026: 15 · 2025: 21 · 2024: 24 · 2023: 23 · 2022: 40 · 2021: 31 · 2020: 56 · 2019: 24 · 2018: 31 · 2017: 30 · 2016: 41 · 2015: 40 · 2014: 40 · 2013: 35 · 2012: 37
- FWCI
- 27.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion, public-domain)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, computer simulation, quality-adjusted life years, diabetes complications, tight glycemic control, health economic evaluation, UKPDS
- MeSH terms
- Amputation, Surgical, Blood Glucose, Cardiovascular Diseases, Computer Simulation, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Diabetic Retinopathy, Female, United Kingdom, Health Status, Humans, Life Expectancy, Male, Middle Aged, Models, Biological, Quality of Life, Risk Factors, Reproducibility of Results, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). https://app.cochat.ai/papers/10.1007/s00125-004-1527-z
- The paper
- Clarke, P. M., Gray, A. M., Briggs, A., Farmer, A. J., Fenn, P., Stevens, R. J., Matthews, D. R., Stratton, I. M., Holman, R. R., & on behalf of the UK Prospective Diabetes Study (UKPDS) Group. (2004). A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia. https://doi.org/10.1007/s00125-004-1527-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.